SCHEMBL12476143

SCHEMBL12476143

CCOc1nc2cccc(C(=O)OC)c2n1Cc1ccc(-c2ccccc2C(=N)NO)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 3/20 0.58
CYP3A4 P08684 2/20 0.58
ADORA3 P0DMS8 2/20 0.58
ADRA2B P18089 2/20 0.58
SLC6A2 P23975 2/20 0.58
AGTR1 P30556 2/20 0.58
PPARG P37231 2/20 0.58
HTR2B P41595 2/20 0.58
PDE3A Q14432 2/20 0.58
ABCB11 O95342 1/20 0.58
EGFR P00533 1/20 0.58
ERBB2 P04626 1/20 0.58
CYP2C9 P11712 1/20 0.58
ADRB3 P13945 1/20 0.58
TBXAS1 P24557 1/20 0.58
HTR2C P28335 1/20 0.58
LTB4R2 Q9NPC1 1/20 0.58
NAE1 Q13564 4/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17998734 0.94 AGTR2 (0.57) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL12527631 0.92 AGTR2 (0.57) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL12096488 0.92 AGTR1 (0.69) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL3977106 0.92 AGTR2 (0.62) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL13857701 0.91 AGTR1 (0.53) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL17998745 0.91 AGTR2 (0.57) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL13465074 0.90 AGTR2 (0.59) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL7018921 0.89 AGTR2 (0.58) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL13281995 0.89 AGTR2 (0.53) AGTR2CYP3A4ADORA3ADRA2BSLC6A2
SCHEMBL17998721 0.89 AGTR2 (0.55) AGTR2CYP3A4ADORA3ADRA2BSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110746415-A Synthesis process for continuously preparing azilsartan under microchannel reactor 南京恒通医药开发有限公司 2020-02-04 CN claimed
EP-2673274-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL Jubilant Life Sciences Limited (IN) 2013-12-18 EP claimed
WO-2012107814-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL JUBILANT LIFE SCIENCES LIMITED (IN) 2012-08-16 WO claimed
CN-108947993-B Method for green and efficient synthesis of azilsartan in water phase 常州大学 2020-04-28 CN disclosed
CN-108752328-B Simple method for synthesizing azilsartan 常州大学 2020-04-24 CN disclosed
EP-2673274-B1 AN IMPROVED PROCESS FOR THE PREPARATION OF AZILSARTAN MEDOXOMIL JUBILANT GENERICS LTD (IN) 2019-07-17 EP disclosed
EP-2681201-B1 A METHOD OF MANUFACTURING 2-ETHOXY-1-(2'-((HYDROXYAMINO)IMINOMETHYL)BIPHENYL-4-YL) METHYL)-1H-BENZO(D)IMIDAZOLE-7-CARBOXYLIC ACID AND ITS ESTERS ZENTIVA KS (CZ) 2016-08-24 EP disclosed
WO-2012157977-A2 MANUFACTURING METHOD OF HETEROCYCLIC COMPOUND HANMI FINE CHEMICAL CO., LTD. (KR) 2012-11-22 WO disclosed
WO-2012139536-A1 A METHOD OF PREPARING 2-ETHOXY-1-((2'-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)BIPHENYL- 4-YL)METHYL)-1H-BENZO[D]IMIDAZOLE-7-CARBOXYLATES AND CONVERSION THEREOF TO AZILSARTAN ZENTIVA, K.S. (CZ) 2012-10-18 WO disclosed
WO-2012139535-A1 A METHOD OF PREPARING 2-ETHOXY-1-((2'-(5-OXO-4,5-DIHYDRO-1,2,4-OXADIAZOL-3-YL)BIPHENYL- 4-YL)METHYL)-1H-BENZO[D]IMIDAZOLE-7-CARBOXYLATES AND CONVERSION THEREOF TO AZILSARTAN ZENTIVA, K.S. (CZ) 2012-10-18 WO disclosed